Transcode Therapeutics Inc
NASDAQ:RNAZ
Transcode Therapeutics Inc
NASDAQ:RNAZ
Price:
0.707 USD
12.26%
Market Closed
Updated:
May 3, 2024
Income Statement
Earnings Waterfall
Transcode Therapeutics Inc
Transcode Therapeutics Inc
|
Revenue
|
0
USD
|
|
Operating Expenses
|
-19.4m
USD
|
|
Operating Income
|
-19.4m
USD
|
|
Other Expenses
|
872.4k
USD
|
|
Net Income
|
-18.5m
USD
|
Income Statement
Transcode Therapeutics Inc
Transcode Therapeutics Inc
Currency: USD
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(6)
|
(9)
|
(14)
|
(16)
|
(19)
|
(20)
|
(21)
|
(21)
|
(19)
|
|
| Selling, General & Administrative |
(3)
|
(5)
|
(7)
|
(7)
|
(8)
|
(9)
|
(9)
|
(9)
|
(7)
|
|
| Research & Development |
(3)
|
(4)
|
(7)
|
(9)
|
(10)
|
(11)
|
(11)
|
(12)
|
(12)
|
|
| Operating Income |
(6)
N/A
|
(9)
-49%
|
(14)
-47%
|
(16)
-19%
|
(19)
-16%
|
(20)
-8%
|
(21)
-2%
|
(21)
-2%
|
(19)
+7%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
(1)
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
|
| Pre-Tax Income |
(7)
N/A
|
(6)
+15%
|
(13)
-128%
|
(15)
-15%
|
(18)
-15%
|
(19)
-8%
|
(19)
+2%
|
(20)
-5%
|
(19)
+5%
|
|
| Net Income | ||||||||||
| Income from Continuing Operations |
(7)
|
(6)
|
(13)
|
(15)
|
(18)
|
(19)
|
(19)
|
(20)
|
(19)
|
|
| Net Income (Common) |
(7)
N/A
|
(6)
+15%
|
(13)
-128%
|
(15)
-15%
|
(18)
-15%
|
(19)
-8%
|
(19)
+2%
|
(20)
-5%
|
(19)
+5%
|
|
| EPS (Diluted) |
-16.28
N/A
|
-8.96
+45%
|
-20.41
-128%
|
-23.43
-15%
|
-27.01
-15%
|
-26.26
+3%
|
-14.07
+46%
|
-6.19
+56%
|
-103.61
-1 574%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
